|
private:springleaftherapeutics
|
2426585
|
Dec 3rd, 2020 12:00AM
|
SpringLeaf Therapeutics
|
44
|
1.00
|
Open
|
Biotechnology
|
Dec 3rd, 2020 01:15PM
|
Dec 3rd, 2020 01:15PM
|
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com.
|
Open
|
|
|
|
|
|
|
|
|
Springleaf Therapeutics
|
|
Financial Services
|
|
private:springleaftherapeutics
|
2426585
|
Dec 2nd, 2020 12:00AM
|
SpringLeaf Therapeutics
|
44
|
1.00
|
Open
|
Biotechnology
|
Dec 2nd, 2020 04:28PM
|
Dec 2nd, 2020 04:28PM
|
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com.
|
Open
|
|
|
|
|
|
|
|
|
Springleaf Therapeutics
|
|
Financial Services
|
|
private:springleaftherapeutics
|
2426585
|
Dec 1st, 2020 12:00AM
|
SpringLeaf Therapeutics
|
44
|
1.00
|
Open
|
Biotechnology
|
Dec 1st, 2020 02:56PM
|
Dec 1st, 2020 02:56PM
|
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com.
|
Open
|
|
|
|
|
|
|
|
|
Springleaf Therapeutics
|
|
Financial Services
|
|
private:springleaftherapeutics
|
2426585
|
Nov 30th, 2020 12:00AM
|
SpringLeaf Therapeutics
|
44
|
1.00
|
Open
|
Biotechnology
|
Nov 29th, 2020 08:58PM
|
Nov 30th, 2020 03:47PM
|
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com.
|
Open
|
|
|
|
|
|
|
|
|
Springleaf Therapeutics
|
|
Financial Services
|
|
private:springleaftherapeutics
|
2426585
|
Nov 28th, 2020 12:00AM
|
SpringLeaf Therapeutics
|
44
|
1.00
|
Open
|
Biotechnology
|
Nov 28th, 2020 04:34PM
|
Nov 28th, 2020 04:34PM
|
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com.
|
Open
|
|
|
|
|
|
|
|
|
Springleaf Therapeutics
|
|
Financial Services
|
|
private:springleaftherapeutics
|
2426585
|
Nov 27th, 2020 12:00AM
|
SpringLeaf Therapeutics
|
44
|
1.00
|
Open
|
Biotechnology
|
Nov 27th, 2020 12:59PM
|
Nov 27th, 2020 12:59PM
|
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com.
|
Open
|
|
|
|
|
|
|
|
|
Springleaf Therapeutics
|
|
Financial Services
|
|
private:springleaftherapeutics
|
2426585
|
Nov 26th, 2020 12:00AM
|
SpringLeaf Therapeutics
|
44
|
1.00
|
Open
|
Biotechnology
|
Nov 25th, 2020 07:52PM
|
Nov 26th, 2020 01:57PM
|
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com.
|
Open
|
|
|
|
|
|
|
|
|
Springleaf Therapeutics
|
|
Financial Services
|
|
private:springleaftherapeutics
|
2426585
|
Nov 24th, 2020 12:00AM
|
SpringLeaf Therapeutics
|
44
|
1.00
|
Open
|
Biotechnology
|
Nov 24th, 2020 03:17PM
|
Nov 24th, 2020 03:17PM
|
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com.
|
Open
|
|
|
|
|
|
|
|
|
Springleaf Therapeutics
|
|
Financial Services
|
|
private:springleaftherapeutics
|
2426585
|
Nov 23rd, 2020 12:00AM
|
SpringLeaf Therapeutics
|
44
|
1.00
|
Open
|
Biotechnology
|
Nov 23rd, 2020 05:14PM
|
Nov 23rd, 2020 05:14PM
|
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com.
|
Open
|
|
|
|
|
|
|
|
|
Springleaf Therapeutics
|
|
Financial Services
|
|
private:springleaftherapeutics
|
2426585
|
Nov 22nd, 2020 12:00AM
|
SpringLeaf Therapeutics
|
44
|
1.00
|
Open
|
Biotechnology
|
Nov 22nd, 2020 04:10PM
|
Nov 22nd, 2020 04:10PM
|
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners. For more information, visit www.springleaftx.com.
|
Open
|
|
|
|
|
|
|
|
|
Springleaf Therapeutics
|
|
Financial Services
|